Farrokh Dehdashti

Senior Vice Chair and Division Director, Nuclear Medicine · Washington University/B-JH/SLCH Consortium

Credentials: · · ·

History

Integration of FTT-PET and ctDNA to Predict Response to PARP Inhibitor Therapy in mPC
National Cancer Institute · R01
Contact PI · $667.5K · Washington University
2026–2031
Interdisciplinary Education in Cancer Imaging and Therapy (EduCAIT)Training Program
National Cancer Institute · T32
PI · $403.4K · Washington University
2026–2031
CCR2 PET Imaging Head and Neck Squamous Cell Carcinoma
National Cancer Institute · R01
Contact PI · $637.4K · Washington University
2026–2031
PET Imaging CD163+ Tumor Associated Macrophages in Head and Neck Cancer
National Cancer Institute · R01
PI · $623.6K · Washington University
2026–2031

[18F]Fluorthanatrace - Positron Emission Tomography (FTT-PET) and ctDNA to Predict Response to PARP Inhibitor Therapy in Metastatic Prostate Cancer (mPC)
Principal investigator · Not yet recruiting · Phase 2
Washington University School of Medicine
2026–2032
CCR2 PET Imaging Head and Neck Squamous Cell Carcinoma
Principal investigator · Not yet recruiting · Phase 2
Washington University School of Medicine
2026–2032
64Cu-LLP2A for Imaging Hematologic Malignancies
Principal investigator · Recruiting · Early phase 1
Washington University School of Medicine
2025–2027
Imaging Apoptosis for Lymphoma Treatment Response
Principal investigator · Terminated · Early phase 1
Washington University School of Medicine
2021–2024